International Journal of STD & AIDS > Volume 18, Number 7 > Pp. 437-439

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Patel, R. Articles by Rutland, E. Search for Related Content PubMed PubMed Citation Social Bookmarking                      What's this?

Reviews

Has episodic treatment of recurrent genital herpes come of age?

Raj Patel and Emma Rutland

Department of Genitourinary Medicine, Royal South Hants Hospital, Southampton, UK; Department of Genitourinary Medicine, Royal South Hants Hospital, Southampton, UK

Genitourinary medicine physicians have two main treatment options for the management of recurrent genital herpes: patient-initiated episodic or continuous suppressive therapy. As well as effective disease control, important factors in selecting a regimen include patient acceptability and potential improvements in quality of life. Traditionally suppressive therapy has been favoured by many genitourinary physicians who have often been sceptical of the benefits of episodic therapy. This view has been challenged by several recent studies demonstrating the efficacy and the comparable psychological benefits of very short patient-initiated episodic therapy compared with suppressive therapy. In this article, we review the theory and development of episodic therapy, and discuss the recent evidence that suggests the benefits of ultra short episodic therapies for recurrent genital herpes may be much greater than previously demonstrated.

Key Words: HERPES SIMPLEX VIRUS • ANTIVIRAL • TREATMENT

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?